Prediction of late distant recurrence in patients with oestrogen-receptor-positive breast cancer: a prospective comparison of the breast-cancer index (BCI) assay, 21-gene recurrence score, and IHC4…

Overview of attention for article published in Lancet Oncology, September 2013

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news: 8 news outlets
twitter: 13 X users
patent: 5 patents

wikipedia: 3 Wikipedia pages
guideline: 6 clinical guideline sources

Readers on

mendeley: 274 Mendeley

So far, Altmetric has seen 14 X posts from 13 X users, with an upper bound of 78,923 followers.

Prediction of late distant recurrence in patients with oestrogen-receptor-positive breast cancer http://t.co/OMiEZgVoDD

BioTheranostics BCI Test May Outperform Oncotype Dx #BreastCancer Test http://t.co/XTHgF2KdCP & http://t.co/KY6honGJdP #pm101 #bcsm

Prediction of late distant recurrence in ER+ Breast Cancer: Comparison of BCI, ODx, and IHC4. http://t.co/mUFpTF8uga

Prediction of late distant recurrence in patients with oestrogen-receptor-positive breast cancer: a prospective c... http://t.co/G3uFWCxOku

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 10 additional X posts.